AmerisourceBergen Corp. (ABC US) sank 3.2 percent, the second-biggest drop in the Standard & Poor's 500 Index, to $37.36. The drug distributor said Chief Financial Officer Michael DiCandilo left the company.
Arch Coal Inc. (ACI US) declined 4.4 percent, the biggest drop in the Russell 1000 Index, to $13.76. The coal mining company was cut to "hold" from "buy" at Brean Murray Carret & Co.
Chelsea Therapeutics International Ltd. (CHTP US) dropped the most in the Russell 2000 Index, sinking 36 percent to $3.19. The biotechnology company said the Food and Drug Administration has placed "increased emphasis on safety data" in its review of the company's Northera drug.
Chesapeake Energy Corp. (CHK US) climbed 1.5 percent to $22.46, after rallying to $23.32, the highest intraday price since Jan. 25. The most active U.S. natural-gas driller said it plans to raise as much as $12 billion this year from asset sales and joint ventures as it seeks to generate enough cash to meet its drilling expenses.
Complete Genomics Inc. (GNOM US) rose the most in the Russell 2000 Index, rallying 39 percent to $4.58. The makers of genomic analysis tools said it was picked by Mayo Clinic to provide human genome sequencing.
Dana Holding Corp. (DAN US) climbed 4.6 percent to $15.97 and reached $16.40 earlier, the highest intraday price since Aug. 2. The maker of vehicle axles and other driveline components may rise this year as it expands in emerging markets and makes environmentally friendly products, Barron's reported, citing Gabelli & Co. analyst Brian Sponheimer.
Diebold Inc. (DBD US) rose 9.1 percent to $37.91 after touching $38.50, the highest intraday price since September 2008. The maker of automated bank-teller machines forecast 2012 earnings per share of $2.30 to $2.50 a share, compared with the average analyst estimate of $2.31, and forecast sales growth of at least 3 percent, beating the average estimate of 2 percent.
Monster Worldwide Inc. (MWW US) fell 3.7 percent to $6.95 after slipping to $6.92, the lowest intraday price since Nov. 29. The world's largest online-recruiting company was cut to "sell" from "neutral" at Citigroup Inc., which cited increasing competition.
Regeneron Pharmaceuticals Inc. (REGN US) jumped 13 percent, the most in the Russell 1000 Index, to $114.85. The drugmaker reported a fourth-quarter adjusted loss per share that was narrower than the average analyst estimate and increased its 2012 U.S. sales forecast for its Eylea treatment for a blindness-causing eye disorder to at least $250 million from no more than $160 million. (source Bloomberg)For the latest updates on the stock market, visit Stock Market Today For the latest updates PRESS CTR + D or visit Stock Market news Today
Related Post:
us stock
- U.S. Stock Futures news today february 14 2013
- U.S. stocks market rose today Rise on Earnings
- Barack Obama invited congressional leaders to the White House a last-ditch effort to broker a deal
- NASDAQ, Dow Jones, S&P Analysis today dec 27 2012
- Chart S&P 500 price target forecast 2013
- Impact U.S. budget crisis stock market drop
- U.S. stock Dow Jones futures Down today
- Analysis Stock market down november 15 2012
- U.S. stock futures Dow Jones rose november 12 2012
- analysis S&P 500 index next week nov 12-16 2012
- Why Stocks market and dollar down after obama win
- Hurricane Sandy will close U.S. stock markets
- Stock market will focus US election next week october 29 2012
- Why Wall Street Stock down october 17 2012
- Impact U.S. Presidential election on financial market november 2012
- U.S. stock futures ahead of payrolls report 10/5/2012
- U.S. stock futures Dow Jones up 9/28 2012
- Dow jones futures outlook september 12 2012
- U.S. stock Dow Jones futures higher september 11 2012
- US. Stocks Market closed september 4 2012
- US. Stock futures higher wait Bernanke speech 8-31-2012
- US Stock Dow jones Futures Down 8/30/2012
- U.S. Stocks Movers 8/27/2012
- US. Stock dow jones futures fell 8/27/2012
- S&P 500 outlook next week august 27-31 2012
No comments:
Post a Comment